GE HealthCare Q1 revenue beats but full-year EPS guidance disappoints

Earnings
โดย StockStory·Read original
Summary · why it matters

GE HealthCare reported first-quarter revenues of $5.13 billion, up 7.4% year on year and exceeding analyst expectations by 2.1%, but the company significantly missed full-year EPS guidance and quarterly EPS estimates. The stock fell 11.1% since the report and now trades at $60.91. Among the 37 healthcare equipment and supplies stocks tracked, aggregate revenues beat consensus by 2.3% while next-quarter revenue guidance came in 1.3% below estimates. STAAR Surgical posted the strongest performance with revenues of $93.52 million, up 120% year on year and beating estimates by 20.8%, while Stryker was the weakest with revenues of $6.02 billion, up 2.6% but missing expectations by 5%.

Impact on stocks 5

Biotech & Genomic Medicine · 3 stocks
Aging Population · 1 stocks
Robotics & Physical AI · 1 stocks